Dx dialogues: diagnosing indolent systemic mastocytosis
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: why staying current with technology is critical in oncology
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: exciting advancements in development for the treatment of cutaneous melanoma
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: using molecular profiling to identify mutations in R/R AML
What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.
An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.
Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.
Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.
Newer estimates reflect major progress against common cancers. Find out why, and how you can protect yourself.